Richtlijn diagnostiek en behandeling van essentiële trombocytose, poycythaemia vera en primaire myelofibrose. 

P.A.W. te Boekhorst, M.-D. Levin, R.A.P. Raymakers, R.E.G. Schutgens, R. van Wijk, K.-S.G. Jie, S. Wittebol, E.C. Dompeling, L.F.R. Span, M.R. de Groot, G.A. Velders en S. Zweegman, namens de Werkgroep Myeloproliferatieve Neoplasieën van de Nederlandse Vereniging voor Haematologie.

Laboratoriumonderzoek bij het gebruik van nieuwe orale anticoagulantia: niet routinematig, maar soms toch noodzakelijk.

Leers MPG, Verhezen P, Jie KS, Hamulyak K.  Nederlands Tijdschrift voor Hematologie 2011;8:330-41.

Platelet doubling after the first azacitidine cycle is a promising predictor for response in myelodysplastic syndromes (MDS), chronic myelomonocytic leukaemia (CMML) and acute myeloid leukaemia (AML) patients in the Dutch azacitidine compassionate named patient programme.

Helm van der LH, Alhan C, Wijermans PW, van Marwijk Kooy M, Schaafsma R, Biemond BJ, Beeker A, Hoogendoorn M, van Rees BP, de Weerdt O, Wegman J, Libourel WJ, Luykx-de Bakker SA, Minnema MC, Brouwer RE, Croon-de Boer F, Eefting M, Jie KS, van de Loosdrecht AA, Koedam J, Veeger NJ, Vellenga E, Huls G.  Br J Haematol. 2011 Dec;155(5):599-606

A randomized phase III study on the effect of thalidomide combined with Adriamycin, dexamethasone (TAD), and high-dose melphalan, followed by thalidomide maintenance in patients with multiple myeloma.

Lokhorst HM, van der Holt B, Zweegman S, Vellenga E, Croockewit S, van Oers MH, von dem Borne P, Wijermans P, Schaafsma R, de Weerdt O, Wittebol S, Delforge M, Berenschot H, Bos GM, Jie KS, Sinnege H, van Marwijk-Kooy M, Joosten P, Minnema MC, Ammerlaan R, Sonneveld P. Blood. 2010 Feb 11;115(6):1113-20

Quality of life after successful treatment of early-stage Hodgkin's lymphoma: 10-year follow-up of the EORTC-GELA H8 randomised controlled trial.

Heutte N, .. Voogt PJ, Wijermans P, Rieux C, Fermé C, Henry-Amar M; EORTC-GELA H8 Trial Group. Lancet Oncol. 2009 Dec;10(12):1160-70

High-dose daunorubicin in older patients with acute myeloid leukemia.

Löwenberg B, Ossenkoppele GJ, van Putten W, Schouten HC, Graux C, Ferrant A, Sonneveld P, Maertens J, Jongen-Lavrencic M, von Lilienfeld-Toal M, Biemond BJ, Vellenga E, van Marwijk Kooy M, Verdonck LF, Beck J, Döhner H, Gratwohl A, Pabst T, Verhoef G; Dutch-Belgian Cooperative Trial Group for Hemato-Oncology (HOVON); German AML Study Group (AMLSG); Swiss Group for Clinical Cancer Research (SAKK) Collaborative Group. N Engl J Med. 2009 Sep 24;361(13):1235-48.

Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparison.

Cornelissen JJ, van der Holt B, Verhoef GE, van't Veer MB, van Oers MH, Schouten HC, Ossenkoppele G, Sonneveld P, Maertens J, van Marwijk Kooy M, Schaafsma MR, Wijermans PW, Biesma DH, Wittebol S, Voogt PJ, Baars JW, Zachée P, Verdonck LF, Löwenberg B, Dekker AW; Dutch-Belgian HOVON Cooperative Group. Blood. 2009 Feb 5;113(6):1375-82.

Interstitiële pneumonitis als bijwerking van thalidomide.

Scholte J, Potjewijd J, Voogt P, Custers F en Jie K-S. Ned Tijdschr Geneeskd. 2009;153:A452

Increased expression of TF on monocytes, but decreased numbers of TF bearing microparticles in blood from patients with acute myocardial infarction.

Keuren JF, Jie KS, Leers MP.Eur J Haematol. 2009 Oct;83(4):387-8.

Risks and benefits of transcatheter thrombolytic therapy in patients with splanchnic venous thrombosis.

Smalberg JH, Spaander MV, Jie KS, Pattynama PM, van Buuren HR, van den Berg B, Janssen HL, Leebeek FW. Thromb Haemost. 2008 Dec;100(6):1084-8.

High D-dimer levels increase the likelihood of pulmonary embolism.

Tick LW, Nijkeuter M, Kramer MH, Hovens MM, Büller HR, Leebeek FW, Huisman MV; Christopher Study Investigators. J Intern Med. 2008 Aug;264(2):195-200.

Low protein Z levels but not the protein Z gene G79A polymorphism are a risk factor for ischemic stroke. van Goor MP, Dippel DW, Jie KS, de Maat MP, Koudstaal PJ, Leebeek FW. Thromb Res. 2008 Mar 29

Primary intestinal follicular lymphoma diagnosed by video capsule endoscopy and double-balloon enteroscopy. van Deursen CT, Goedhard JG, Jie KS, Theunissen P. Endoscopy. 2008 Feb 18.

Thrombotic and infectious complications of central venous catheters in patients with hematological malignancies. Boersma RS, Jie KS, Verbon A, van Pampus EC, Schouten HC. Ann Oncol. 2008 Mar;19(3):433-42. Epub 2007 Oct 24. Review.

UGT1A1*28 genotype and irinotecan dosage in patients with metastatic colorectal cancer: a Dutch Colorectal Cancer Group study.

 Kweekel DM, Gelderblom H, Van der Straaten T, Antonini NF, Punt CJ, Guchelaar HJ; Dutch Colorectal Cancer Group study. Br J Cancer. 2008 Jul 22;99(2):275-82.

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial.

 Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, Bechstein WO, Primrose JN, Walpole ET, Finch-Jones M, Jaeck D, Mirza D, Parks RW, Collette L, Praet M, Bethe U, Van Cutsem E, Scheithauer W, Gruenberger T. Lancet. 2008 Mar 22;371(9617):1007-16.

Trombotic and infectious complications of central venous catheters in patients with hemotological malignancies.

R.S. Boersma, K.-S. G. Jie, A. Verbon, E.C.M. van Pampus & H.C. Schouten

Randomised study of sequential versus combination chemotherapy with capecitabine, irinotecan and oxaliplatin in advanced colorectal cancer, an interim safety analysis. A Dutch Colorectal Cancer Group (DCCG) phase III study.

Koopman M, Antonini NF, Douma J, Wals J, Honkoop AH, Erdkamp FL, de Jong RS, Rodenburg CJ, Vreugdenhil G, Akkermans-Vogelaar JM, Punt CJ. Ann Oncol. 2006 Oct;17(10):1523-8.

Mutation of FLT3 is not a general phenomenon in CD117-positive T-ALL.

Scharnhorst V, Wals J, Beverloo HB, Langerak AW, van der Velden VH. Leuk Res. 2006 Feb;30(2):245-6.

A case of abdominal mesothelioma diagnosed by indium-III leucocyte scintigraphy. Vestjens JH, Rahnama MS, Brans BT, Buijs J. Neth J Med. 2006 Jan;65(1):43; autho reply 43.

Do- it-yourself thermotherapy for prostate carcinoma. J. Buijs, R.S. Boersma British Medical Journal, april 2006;332;841

Reversibele posterieure leuco-encefalopathie bij hypercalciemie.C.M.C. Klomp, M.W.C. van den Broek, J. Buijs, R. Beekman Ned Tijdschr Geneeskd 2006, 4 maart 150(9), p505-508

Simultaneous bilateral spontaneous pneumothorax as a presenting symptom of osteosarcoma.

Boersma RS, Buijs J. Eur J Intern Med. 2007 Jul;18(4):342-3.

Adjuvant regional chemotherapy and systemic chemotherapy versus systemic chemotherapy alone in patients with stage II-III colorectal cancer: a multicentre randomised controlled phase III trial.

Nordlinger B, Rougier P, Arnaud JP, Debois M, Wils J, Ollier JC, Grobost O, Lasser P, Wals J, Lacourt J, Seitz JF, Guimares dos Santos J, Bleiberg H, Mackiewickz R, Conroy T, Bouché O, Morin T, Baila L, van Cutsem E, Bedenne L. Lancet Oncol. 2005 Jul;6(7):459-68.

Interferon-alpha as maintenance therapy in patients with multiple myeloma.

Schaar CG, Kluin-Nelemans HC, Te Marvelde C, le Cessie S, Breed WP, Fibbe WE, van Deijk WA, Fickers MM, Roozendaal KJ, Wijermans PW; Dutch-Belgian Hemato-Oncology Cooperative Group HOVON. Ann Oncol. 2005 Apr;16(4):634-9.

High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962.

 Poortmans PM, Kluin-Nelemans HC, Haaxma-Reiche H, Van't Veer M, Hansen M, Soubeyran P, Taphoorn M, Thomas J, Van den Bent M, Fickers M, Van Imhoff G, Rozewicz C, Teodorovic I, van Glabbeke M; European Organization for Research and Treatment of Cancer Lymphoma Group. J Clin Oncol. 2003 Dec 15;21(24):4483-8

The effect of optimal treatment on elderly patients with aggressive non-Hodgkin's lymphoma: more patients treated with unaffected response rates.

 Peters FP, Fickers MM, Erdkamp FL, Wals J, Wils JA, Schouten HC. Ann Hematol. 2001 Jul;80(7):406-10.

Paraneoplastic pemphigus as the initial presentation of chronic lymphocytic leukemia.

 van Mook WNK, Fickers MM, Theunissen PH, van der Kley JA, Duijvestijn JA, Pas HH, Flikweert DC. Ann Oncol. 2001 Jan;12(1):115-8.

Clinical and immunological evaluation of primary splenic irradiation in chronic lymphocytic leukemia: a study of 24 cases.

 van Mook WN, Fickers MM, Verschueren TA. Ann Hematol. 2001 Apr;80(4):216-23.

A case of herpes-like Sweet's syndrome in acute myelogenous leukemia during treatment with G-CSF.

van Mook WN, Fickers MM, van der Kley JA, Theunissen PH. Neth J Med. 1999 Nov;55(5):235-41.

Treatment of elderly patients with intermediate- and high-grade non-Hodgkin's lymphoma: a retrospective population-based study.

 Peters FP, Lalisang RI, Fickers MM, Erdkamp FL, Wils JA, Houben SG, Wals J, Schouten HC. Ann Hematol. 2001 Mar;80(3):155-9.

Dose-dense epirubicin and paclitaxel with G-CSF: a study of decreasing intervals in metastatic breast cancer.

 Lalisang RI, Voest EE, Wils JA, Nortier JW, Erdkamp FL, Hillen HF, Wals J, Schouten HC, Blijham GH. Br J Cancer. 2000 Jun;82(12):1914-9.

Cyclophosphamide, epirubicin and cisplatin (CEP) versus epirubicin plus cisplatin (EP) in stage Ic-IV ovarian cancer: a randomized phase III trial of the Gynecologic Oncology Group of the Comprehensive Cancer Center Limburg.

 Wils J, van Geuns H, Stoot J, Bergmans M, Boschma F, Bron H, Degen J, Erdkamp F, van Erp J, Haest J, Iding R, Lalisang F, de Pree N, de Rooy C, Snijders M, Schepers J, Vreeswijk J, Wals J, Werter M, Wetzels L, Smeets J, Schouten L. Anticancer Drugs. 1999 Mar;10(3):257-61.

Efficacy of carboplatin plus primary prophylactic filgrastim (granulocyte colony stimulating factor) in relapsed ovarian cancer: a study of the Gynecologic Oncology Group of the Comprehensive Cancer Center Limburg.

Wils JA, van Geuns H, Wals J, Vreeswijk J, Lalisang F. Anticancer Drugs. 1997 Jun;8(5):432-5.